328 related articles for article (PubMed ID: 27940934)
1. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
[TBL] [Abstract][Full Text] [Related]
2. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
3. Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.
Dan GA; Badila E; Weiss E; Laroche C; Boriani G; Dan A; Tavazzi L; Maggioni AP; Crijns HJ; Popescu R; Blommaert D; Streb W; Lip GYH;
Int J Cardiol; 2018 Mar; 254():136-141. PubMed ID: 29407080
[TBL] [Abstract][Full Text] [Related]
4. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
[TBL] [Abstract][Full Text] [Related]
6. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
[TBL] [Abstract][Full Text] [Related]
7. Peripheral arterial disease and risk of atrial fibrillation and stroke: the Multi-Ethnic Study of Atherosclerosis.
O'Neal WT; Efird JT; Nazarian S; Alonso A; Heckbert SR; Soliman EZ
J Am Heart Assoc; 2014 Nov; 3(6):e001270. PubMed ID: 25404190
[TBL] [Abstract][Full Text] [Related]
8. Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Boriani G; Laroche C; Diemberger I; Popescu MI; Rasmussen LH; Sinagra G; Dan GA; Maggioni AP; Tavazzi L; Lane DA; Lip GYH;
Europace; 2017 Apr; 19(4):535-543. PubMed ID: 28431068
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
[TBL] [Abstract][Full Text] [Related]
10. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.
Boriani G; Proietti M; Laroche C; Diemberger I; Popescu MI; Riahi S; Shantsila A; Dan GA; Tavazzi L; Maggioni AP; Lip GYH;
Int J Cardiol; 2018 Nov; 271():68-74. PubMed ID: 30001945
[TBL] [Abstract][Full Text] [Related]
11. Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries.
Proietti M; Laroche C; Nieuwlaat R; Crijns HJGM; Maggioni AP; Lane DA; Boriani G; Lip GYH; ;
Eur J Intern Med; 2018 Sep; 55():28-34. PubMed ID: 29778588
[TBL] [Abstract][Full Text] [Related]
12. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.
Boriani G; Proietti M; Laroche C; Fauchier L; Marin F; Nabauer M; Potpara T; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GYH;
Europace; 2019 Jul; 21(7):1013-1022. PubMed ID: 30904925
[TBL] [Abstract][Full Text] [Related]
13. 'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase.
Proietti M; Laroche C; Opolski G; Maggioni AP; Boriani G; Lip GYH;
Europace; 2017 May; 19(5):722-733. PubMed ID: 27194538
[TBL] [Abstract][Full Text] [Related]
14. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
15. Atrial Fibrillation and Surgical Patients with Peripheral Arterial Disease.
González-Fajardo JA; Ansuategui M; Romero C; Comanges A; Cases C; Gómez-Arbeláez D
Ann Vasc Surg; 2020 Aug; 67():411-416. PubMed ID: 32209417
[TBL] [Abstract][Full Text] [Related]
16. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Eur J Heart Fail; 2015 Jun; 17(6):570-82. PubMed ID: 25727992
[TBL] [Abstract][Full Text] [Related]
17. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
[TBL] [Abstract][Full Text] [Related]
18. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study.
Proietti M; Nobili A; Raparelli V; Napoleone L; Mannucci PM; Lip GY;
Clin Res Cardiol; 2016 Nov; 105(11):912-920. PubMed ID: 27245329
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial.
Proietti M; Raparelli V; Olshansky B; Lip GY
Clin Res Cardiol; 2016 May; 105(5):412-20. PubMed ID: 26525391
[TBL] [Abstract][Full Text] [Related]
20. Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly.
Griffin WF; Salahuddin T; O'Neal WT; Soliman EZ
Europace; 2016 Jun; 18(6):794-8. PubMed ID: 26589625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
